Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas

被引:94
作者
Pezzilli, Raffaele [1 ]
Andriulli, Angelo [1 ]
Bassi, Claudio [1 ]
Balzano, Gianpaolo [1 ]
Cantore, Maurizio [1 ]
Delle Fave, Gianfranco [1 ]
Falconi, Massimo [1 ]
Frulloni, Luca [1 ]
机构
[1] Internal Med St Orsola Malpighi Hosp, Dept Digest Dis, I-40138 Bologna, Italy
关键词
Exocrine pancreatic insufficiency; Chronic pancreatitis; Gastric surgery; Pancreatic surgery; Pancreatic neoplasms; Risk factors; Clinical studies; FECAL ELASTASE-1 CONCENTRATIONS; PARENTERAL-NUTRITION SUPPORT; ENZYME SUBSTITUTION THERAPY; CELIAC-DISEASE; DIABETES-MELLITUS; DOUBLE-BLIND; BREATH TEST; PROSPECTIVE MULTICENTER; PROGNOSTIC-FACTORS; TOTAL GASTRECTOMY;
D O I
10.3748/wjg.v19.i44.7930
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This is a medical position statement developed by the Exocrine Pancreatic Insufficiency collaborative group which is a part of the Italian Association for the Study of the Pancreas (AISP). We covered the main diseases associated with exocrine pancreatic insufficiency (EPI) which are of common interest to internists/gastroenterologists, oncologists and surgeons, fully aware that EPI may also occur together with many other diseases, but less frequently. A preliminary manuscript based on an extended literature search (Medline/PubMed, Cochrane Library and Google Scholar) of published reports was prepared, and key recommendations were proposed. The evidence was discussed at a dedicated meeting in Bologna during the National Meeting of the Association in October 2012. Each of the proposed recommendations and algorithms was discussed and an initial con-sensus was reached. The final draft of the manuscript was then sent to the AISP Council for approval and/or modification. All concerned parties approved the final version of the manuscript in June 2013. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:7930 / 7946
页数:17
相关论文
共 156 条
[1]  
Amann ST, 1997, AM J GASTROENTEROL, V92, P2280
[2]  
ANGELINI G, 1988, INT J PANCREATOL, V3, P185
[3]  
ARMBRECHT U, 1988, Alimentary Pharmacology and Therapeutics, V2, P493
[4]   Surgical treatment of benign and borderline neoplasms of the pancreatic body [J].
Balzano, G ;
Zerbi, A ;
Veronesi, P ;
Cristallo, M ;
Di Carlo, V .
DIGESTIVE SURGERY, 2003, 20 (06) :506-510
[5]   How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? [J].
Beharry, S ;
Ellis, L ;
Corey, M ;
Marcon, M ;
Durie, P .
JOURNAL OF PEDIATRICS, 2002, 141 (01) :84-90
[6]   Development and Physiological Regulation of Intestinal Lipid Absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion [J].
Black, Dennis D. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 293 (03) :G519-G524
[7]   STUDIES OF INTESTINAL DIGESTION AND ABSORPTION IN THE HUMAN [J].
BORGSTROM, B ;
DAHLQVIST, A ;
LUNDH, G ;
SJOVALL, J .
JOURNAL OF CLINICAL INVESTIGATION, 1957, 36 (10) :1521-1536
[8]  
Borowitz Drucy, 2007, J Pediatr Pharmacol Ther, V12, P47, DOI 10.5863/1551-6776-12.1.47
[9]  
Brägelmann R, 1999, EUR J GASTROEN HEPAT, V11, P231
[10]  
BRUNO MJ, 1995, AM J GASTROENTEROL, V90, P1383